Skip to content
Hair Pipeline
enfr
← Back to the pipeline

Epibiotech dermal papilla cell therapy

Epibiotech dermal papilla cell therapy is in Phase 1/2 for androgenetic alopecia, developed by Epibiotech.

The patient's own dermal papilla cells, multiplied in a lab and injected back into the scalp.

Phase 1/2Cell therapyInjectableStem cell activation

Monthly digest of verified phase changes. A confirmation link goes out first; unsubscribe is one click on every mail.

Developed by
Epibiotech
Current phase
Phase 1/2

A combined safety and early-efficacy study.

Mechanism
Stem cell activation

Uses stem or progenitor cells to regenerate or replace follicle tissue.

Indications
Androgenetic alopecia
Also known as
EPI-001, Stemore
Last public activity
June 2026
Copy last reviewed
August 2026
Record confidence
Medium

A research record, not medical advice: being listed here says nothing about whether a treatment works or whether it is right for you. Talk to a dermatologist about your own case.

How it is meant to work

Dermal papilla cells are the follicle's instruction set — they tell surrounding tissue to build a hair. Take a small biopsy, expand those cells in culture, put them back where follicles have miniaturised, and in principle you restore the signal that has been lost.

Development history

  1. Phase 1Phase 1/2

    Registered on ClinicalTrials.gov as NCT07618195: Study of EPI-001 in Patients With Androgenetic Alopecia

    ClinicalTrials.gov ↗

Registered trials

Pulled automatically from ClinicalTrials.gov. Matching is by name and development code, so occasional gaps are possible — tell us if you spot one.

  • NCT07618195Phase 1/2Recruiting

    Study of EPI-001 in Patients With Androgenetic Alopecia

    Epibiotech · n=42 · January 2026

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first.

Sources

Related programmes

Other programmes in the register with the same mechanism: Stem cell activation.

Cite this page

Hair Pipeline, "Epibiotech dermal papilla cell therapy — development record", hairpipeline.com/pipeline/epibiotech-epi-001